NCT00417326已完成2 期
ONO-5046Na Phase II Study - A Pilot Study for Patients With Acute Respiratory Failure
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 174
- 试验地点
- 9
- 主要终点
- pulmonary function
研究概览
简要总结
The purpose of this study is to determine the safety and efficacy of ONO-5046Na in patients with acute respiratory failure associated with community-acquired pneumonia
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 20 Years 至 79 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with community-acquired pneumonia
- •Patients with acute respiratory failure
排除标准
- •Patients with nosocomial pneumonia
- •Patients on mechanical ventilation
研究组 & 干预措施
P
Placebo Comparator
干预措施: ONO-5046Na (Drug)
E
Experimental
干预措施: ONO-5046Na (Drug)
结局指标
主要结局
pulmonary function
时间窗: 14 days
次要结局
- mortality(28 days)
- ventilator status(28 days)
研究者
研究点 (9)
Loading locations...
相似试验
已完成
1 期
A Phase I Study of OCV-501 in Acute Myeloid Leukemia PatientsAcute Myeloid LeukemiaNCT01440920Otsuka Pharmaceutical Co., Ltd.9
已完成
2 期
ONO-4538 Study in Patients With Advanced Non-Small Cell Lung CancerAdvanced Non-small Cell Lung Cancer (NSCLC)NCT02175017Ono Pharmaceutical Co. Ltd104
已完成
2 期
Study of ONO-2506 in Patients With Acute Ischemic StrokeStrokeNCT00229177Ono Pharmaceutical Co. Ltd757
已完成
3 期
Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric CancerGastric CancerNCT02267343Ono Pharmaceutical Co. Ltd493
已完成
2 期
ONO-4538 Study in Patients With Advanced Non-Small Cell Lung CancerAdvanced Non-small Cell Lung CancerNCT02582125Ono Pharmaceutical Co. Ltd53